tradingkey.logo
搜索

Lifecore Biomedical Inc

LFCR
添加自选
5.090USD
-0.180-3.42%
收盘 07/02, 13:00美东报价延迟15分钟
190.76M总市值
亏损市盈率 TTM

关于 Lifecore Biomedical Inc 公司

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Lifecore Biomedical Inc简介

公司代码LFCR
公司名称Lifecore Biomedical Inc
上市日期Feb 15, 1996
CEOJosephs (Paul)
员工数量406
证券类型Ordinary Share
年结日Feb 15
公司地址3515 Lyman Boulevard
城市CHASKA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编55318
电话19523684300
网址https://www.lifecore.com/
公司代码LFCR
上市日期Feb 15, 1996
CEOJosephs (Paul)

Lifecore Biomedical Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
25.91K
--
Mr. Christopher S. Kiper
Mr. Christopher S. Kiper
Independent Director
Independent Director
25.91K
--
Katrina L. Houde
Katrina L. Houde
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Paul H. Johnson
Mr. Paul H. Johnson
Independent Director
Independent Director
--
--
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
25.91K
--

常见问题

Lifecore Biomedical Inc的前五大股东是谁?

Lifecore Biomedical Inc 的前五大股东如下:Mr. Paul Josephs

有多少机构持有Lifecore Biomedical Inc(LFCR)的股份?

截至2026Q1,共有225家机构持有Lifecore Biomedical Inc的股份,合计持有的股份价值约为30.56M,占公司总股份的81.48%。与2025Q4相比,机构持股有所增加,增幅为1031462.00。

哪个业务部门对Lifecore Biomedical Inc的收入贡献最大?

在2026Q1,Contract development and manufacturing organization ("CDMO")业务部门对Lifecore Biomedical Inc的收入贡献最大,创收17.81M,占总收入的64.53%。